Sc6PT
Sc6PT is launching its first IPT with Moon Drops, a novel CE Ferulic formulation that improves upon existing gold-standard serums. Unlike traditional CE Ferulic products, DermaDAO’s formulation replaces flagged ingredients with a cleaner INCI list, ensuring a safer and more sustainable profile while significantly reducing production costs.
Community Sentiment
How do you feel about this ipt?
Community Sentiment
How do you feel about this ipt?
Project
Market Overview
CE Ferulic serums combine Vitamin C, Vitamin E, and Ferulic Acid and are widely used in dermatology and consumer skincare. However, leading formulations contain ingredients with flagged safety concerns and are prohibitively expensive for large-scale adoption. DermaDAO has developed a clean formulation with 100% safe INCI, improved potency, and significantly reduced cost of goods, without compromising on efficacy or sensory profile.
This IPT funds the validation and first consumer deployment of the new formulation, gathering evidence through QR/selfie-based community studies. By tokenizing this IP and research process, DermaDAO builds the foundation for decentralized dermatology innovation.
Market Overview
CE Ferulic serums combine Vitamin C, Vitamin E, and Ferulic Acid and are widely used in dermatology and consumer skincare. However, leading formulations contain ingredients with flagged safety concerns and are prohibitively expensive for large-scale adoption. DermaDAO has developed a clean formulation with 100% safe INCI, improved potency, and significantly reduced cost of goods, without compromising on efficacy or sensory profile.
This IPT funds the validation and first consumer deployment of the new formulation, gathering evidence through QR/selfie-based community studies. By tokenizing this IP and research process, DermaDAO builds the foundation for decentralized dermatology innovation.
- Primary capture: IPT sale funds formulation validation and product deployment.
- Upside for holders: Participation in value creation around IP — cleaner CE Ferulic complex could be licensed, manufactured at scale, or spun into derivative products.
- Future growth: Roadmap includes peptide-based serums and companion products (e.g., sunscreen) which can also be tokenized as IPTs.
- DAO layer: Treasury allocation supports community-driven governance on future R&D and commercialization choices.
Dongsinne Sohn
Co-founder, DermaDAO. Leads operations, dermatology strategy.
Jez Marston
Co-founder, DermaDAO. Focus on community and comms.
IPT launch for CE Ferulic at Korea Blockchain Week
Consumer validation study via QR/selfie funnel, data collection begins
Publication of results and preparation of next IPT (peptide-based serum)
Scale manufacturing and initiate DAO governance for product pipeline
Tokenomics
100,000
Total SupplyIgnition Sale | 37.5% |
LP (BIO/Token) | 12% |
treasury | 38% |
team | 10% |
BIO | 2% |
100,000
Total SupplyIgnition Sale | 37.5% |
LP (BIO/Token) | 12% |
treasury | 38% |
team | 10% |
BIO | 2% |
Community
Stay up to date
Get the latest community updates and find out about upcoming Sc6PT developments
